Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Clinical trial NCT07504458 · RECRUITING

Trial details

NCT number: NCT07504458
Sponsor: Quetzal Therapeutics
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Promyelocytic Leukemia (APL)Acute Promyelocytic Leukaemia Acute Promyelocytic Leukemia With PML-RARA Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA Acute Promyelocytic Leukemia

Start date: 2026-06-08
Primary completion: 2027-03-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.